IFN-III and IFN-I were also significantly upregulated in COVID-19 patients relative to controls and when compared to patients with ARDS of different etiologies (except for IFN-λ1) (Figure 6A–6D; STAR Methods). Here, IFNL1 is linked to COVID-19.